We randomly assigned 208 patients who underwent brain biopsy for presumptive herpes simplex encephalitis to receive either vidarabine (15 mg per kilogram of body weight per day) or acyclovir (30 mg per kilogram per day) for 10 days. Sixty-nine patients (33 percent) had biopsy-proved disease; 37 received vidarabine, and 32 acyclovir. The mortality in the vidarabine recipients was 54 percent, as compared with 28 percent in the acyclovir recipients (P = 0.008). Six-month mortality varied according to the Glasgow coma score at the onset of therapy. For scores of greater than 10, 7 to 10, and less than or equal to 6, mortality was 42, 46, and 67 percent in the patients treated with vidarabine, as compared with 0, 25, and 25 percent in those treated with acyclovir. A six-month morbidity assessment using an adapted scoring system revealed that 5 of 37 patients receiving vidarabine (14 percent) as compared with 12 of 32 receiving acyclovir (38 percent) were functioning normally (P = 0.021). Eight vidarabine-treated patients (22 percent) and three acyclovir-treated patients (9 percent) had moderate debility. Patients under 30 years of age and with a Glasgow coma score above 10 had the best outcome with acyclovir treatment. We conclude that acyclovir is currently the treatment of choice for biopsy-proved herpes simplex encephalitis.
This article has been cited by other articles:
LeBlanc, J. J., Campbell, S., Pettipas, J., Hatchette, T. F., Davidson, R. J.
(2008). Herpes Simplex Virus Type 2 Displays Atypical Melting-Temperature Profiles at Low Viral Titers. J. Clin. Microbiol.
46: 2786-2789
[Abstract][Full Text]
Berger, J. R., Houff, S.
(2008). Neurological Complications of Herpes Simplex Virus Type 2 Infection. Arch Neurol
65: 596-600
[Abstract][Full Text]
Solomon, T., Hart, I. J, Beeching, N. J
(2007). Viral encephalitis: a clinician's guide. PN
7: 288-305
[Abstract][Full Text]
Hanson, K. E., Alexander, B. D., Woods, C., Petti, C., Reller, L. B.
(2007). Validation of Laboratory Screening Criteria for Herpes Simplex Virus Testing of Cerebrospinal Fluid. J. Clin. Microbiol.
45: 721-724
[Abstract][Full Text]
Casrouge, A., Zhang, S.-Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., Alcais, A., Picard, C., Mahfoufi, N., Nicolas, N., Lorenzo, L., Plancoulaine, S., Senechal, B., Geissmann, F., Tabeta, K., Hoebe, K., Du, X., Miller, R. L., Heron, B., Mignot, C., de Villemeur, T. B., Lebon, P., Dulac, O., Rozenberg, F., Beutler, B., Tardieu, M., Abel, L., Casanova, J.-L.
(2006). Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency. Science
314: 308-312
[Abstract][Full Text]
Chadwick, D. R.
(2006). Viral meningitis. Br Med Bull
75-76: 1-14
[Abstract][Full Text]
Kamei, S, Sekizawa, T, Shiota, H, Mizutani, T, Itoyama, Y, Takasu, T, Morishima, T, Hirayanagi, K
(2005). Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J. Neurol. Neurosurg. Psychiatry
76: 1544-1549
[Abstract][Full Text]
Buursma, A. R., de Vries, E. F. J., Garssen, J., Kegler, D., van Waarde, A., Schirm, J., Hospers, G. A. P., Mulder, N. H., Vaalburg, W., Klein, H. C.
(2005). [18F]FHPG Positron Emission Tomography for Detection of Herpes Simplex Virus (HSV) in Experimental HSV Encephalitis. J. Virol.
79: 7721-7727
[Abstract][Full Text]
Lewin, J. J. III, Lapointe, M., Ziai, W. C.
(2005). Central Nervous System Infections in the Critically Ill. Journal of Pharmacy Practice
18: 25-41
[Abstract]
Chataway, J., Davies, N.W.S., Farmer, S., Howard, R.S., Thompson, E.J., Ward, K.N.
(2004). Herpes simplex encephalitis: an audit of the use of laboratory diagnostic tests. QJM
97: 325-330
[Abstract][Full Text]
Tang, J W, Coward, L J, Davies, N W S, Geretti, A M, Howard, R S, Hirsch, N P, Ward, K N
(2003). Brain stem encephalitis caused by primary herpes simplex 2 infection in a young woman. J. Neurol. Neurosurg. Psychiatry
74: 1323-1325
[Abstract][Full Text]
Crumpacker, C. S., Gonzalez, R. G., Makar, R. S.
(2003). Case 26-2003 - A 50-Year-Old Colombian Man with Fever and Seizures. NEJM
349: 789-796
[Full Text]
Kennedy, P G E
(2003). Neurovirological methods and their applications. J. Neurol. Neurosurg. Psychiatry
74: 1016-1022
[Abstract][Full Text]
Harrison, N A, MacDonald, B K, Scott, G, Kapoor, R
(2003). Atypical herpes type 2 encephalitis associated with normal MRI imaging. J. Neurol. Neurosurg. Psychiatry
74: 974-976
[Abstract][Full Text]
Yamada, S, Kameyama, T, Nagaya, S, Hashizume, Y, Yoshida, M
(2003). Relapsing herpes simplex encephalitis: pathological confirmation of viral reactivation. J. Neurol. Neurosurg. Psychiatry
74: 262-264
[Abstract][Full Text]
Chaudhuri, A, Kennedy, P G E
(2002). Diagnosis and treatment of viral encephalitis. Postgrad. Med. J.
78: 575-583
[Abstract][Full Text]
Kennedy, P G E, Chaudhuri, A
(2002). Herpes simplex encephalitis. J. Neurol. Neurosurg. Psychiatry
73: 237-238
[Full Text]
Smalling, T. W., Sefers, S. E., Li, H., Tang, Y.-W.
(2002). Molecular Approaches To Detecting Herpes Simplex Virus and Enteroviruses in the Central Nervous System. J. Clin. Microbiol.
40: 2317-2322
[Full Text]
Solomon, T., Dung, N. M., Kneen, R., Thao, L. T. T., Gainsborough, M., Nisalak, A., Day, N. P. J., Kirkham, F. J., Vaughn, D. W., Smith, S., White, N. J.
(2002). Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain
125: 1084-1093
[Abstract][Full Text]
Markoulatos, P., Georgopoulou, A., Siafakas, N., Plakokefalos, E., Tzanakaki, G., Kourea-Kremastinou, J.
(2001). Laboratory Diagnosis of Common Herpesvirus Infections of the Central Nervous System by a Multiplex PCR Assay. J. Clin. Microbiol.
39: 4426-4432
[Abstract][Full Text]
Bidanset, D. J., Placidi, L., Rybak, R., Palmer, J., Sommadossi, J.-P., Kern, E. R.
(2001). Intravenous Infusion of Cereport Increases Uptake and Efficacy of Acyclovir in Herpes Simplex Virus-Infected Rat Brains. Antimicrob. Agents Chemother.
45: 2316-2323
[Abstract][Full Text]
Kimberlin, D. W., Lin, C.-Y., Jacobs, R. F., Powell, D. A., Frenkel, L. M., Gruber, W. C., Rathore, M., Bradley, J. S., Diaz, P. S., Kumar, M., Arvin, A. M., Gutierrez, K., Shelton, M., Weiner, L. B., Sleasman, J. W., de Sierra, T. M., Soong, S.-J., Kiell, J., Lakeman, F. D., Whitley, R. J., the National Institute of Allergy and Infectious D,
(2001). Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era. Pediatrics
108: 223-229
[Abstract][Full Text]
Kimberlin, D. W., Lin, C.-Y., Jacobs, R. F., Powell, D. A., Corey, L., Gruber, W. C., Rathore, M., Bradley, J. S., Diaz, P. S., Kumar, M., Arvin, A. M., Gutierrez, K., Shelton, M., Weiner, L. B., Sleasman, J. W., de Sierra, T. M., Weller, S., Soong, S.-J., Kiell, J., Lakeman, F. D., Whitley, R. J., the National Institute of Allergy and Infectious D,
(2001). Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections. Pediatrics
108: 230-238
[Abstract][Full Text]
Leonard, J. R., Moran, C. J., Cross, D. T. III, Wippold, F. J. II, Schlesinger, Y., Storch, G. A.
(2000). MR Imaging of Herpes Simplex Type I Encephalitis in Infants and Young Children: A Separate Pattern of Findings. Am. J. Roentgenol.
174: 1651-1655
[Abstract][Full Text]
Hofgartner, W. T., Huhmer, A. F.R., Landers, J. P., Kant, J. A.
(1999). Rapid Diagnosis of Herpes Simplex Encephalitis Using Microchip Electrophoresis of PCR Products. Clin. Chem.
45: 2120-2128
[Abstract][Full Text]
Hunter, W. D., Martuza, R. L., Feigenbaum, F., Todo, T., Mineta, T., Yazaki, T., Toda, M., Newsome, J. T., Platenberg, R. C., Manz, H. J., Rabkin, S. D.
(1999). Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates. J. Virol.
73: 6319-6326
[Abstract][Full Text]
Tang, Y.-W., Mitchell, P. S., Espy, M. J., Smith, T. F., Persing, D. H.
(1999). Molecular Diagnosis of Herpes Simplex Virus Infections in the Central Nervous System. J. Clin. Microbiol.
37: 2127-2136
[Full Text]
Balfour, H. H.
(1999). Antiviral Drugs. NEJM
340: 1255-1268
[Full Text]
Lahat, E, Barr, J, Barkai, G, Paret, G, Brand, N, Barzilai, A
(1999). Long term neurological outcome of herpes encephalitis. Arch. Dis. Child.
80: 69-71
[Abstract][Full Text]
Tang, Y.-W., Rys, P. N., Rutledge, B. J., Mitchell, P. S., Smith, T. F., Persing, D. H.
(1998). Comparative Evaluation of Colorimetric Microtiter Plate Systems for Detection of Herpes Simplex Virus in Cerebrospinal Fluid. J. Clin. Microbiol.
36: 2714-2717
[Abstract][Full Text]
Domingues, R. B., Lakeman, F. D., Mayo, M. S., Whitley, R. J.
(1998). Application of Competitive PCR to Cerebrospinal Fluid Samples from Patients with Herpes Simplex Encephalitis. J. Clin. Microbiol.
36: 2229-2234
[Abstract][Full Text]
Kurokawa, M., Hozumi, T., Basnet, P., Nakano, M., Kadota, S., Namba, T., Kawana, T., Shiraki, K.
(1998). Purification and Characterization of Eugeniin as an Anti-herpesvirus Compound from Geum japonicum and Syzygium aromaticum. J. Pharmacol. Exp. Ther.
284: 728-735
[Abstract][Full Text]
McGrath, N, Anderson, N E, Croxson, M C, Powell, K F
(1997). Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J. Neurol. Neurosurg. Psychiatry
63: 321-326
[Abstract][Full Text]
Hokkanen, L., Launes, J.
(1997). Cognitive recovery instead of decline after acute encephalitis: a prospective follow up study. J. Neurol. Neurosurg. Psychiatry
63: 222-227
[Abstract][Full Text]
Shafran, S. D., Thompson, N.
(1996). Herpes Simplex Encephalitis. NEJM
335: 209-209
[Full Text]
Wang, H.-S., Huang, S.-C.
(1993). Value of Serum Anti-Herpes Simplex Viral IgM Antibody Testing in Empirical Antiviral Treatment of Herpes Simplex Encephalitis. J Child Neurol
8: 378-382
[Abstract]
Elion, G.
(1989). The purine path to chemotherapy. Science
244: 41-47
[Abstract]
Sawyer, J., Ellner, J., Ransohoff, D. F.
(1988). To Biopsy or Not to Biopsy in suspected Herpes Simplex Encephalitis: A Quantitatiue Analysis. Med Decis Making
8: 95-101
[Abstract]